Composition
Each tablet contains Nalidixic acid 500 mg.
Indications
- Urinary tract infections: it acts at any pH either acidic or alkaline urine.
- Shigella (Bacillary dysentery )resistant to antimicrobials.
- In patients hypersensitive to penicillin or sulphonamide.
Precautions
- Given with care in patients with renal and hepatic failure.
- It enhances the effect of oral anti-coagulant as warfarin so the dose of anti-coagulant may need to be reduced.
- It shouldn’t be used in pregnancy and lactation.
Dosage
- Adults: 8 tablets daily for one or two weeks. If prolonged treatment is required, the dose is reduced to 4 tablets daily.
- Children :55 mg./kg. of B. wt. daily in divided doses.
Package
- Pack of 20 tablets in 2 strips, each of 10 tablets.
- Pack of 1000 tablets in 100 strips, each of 10 tablets (hospital pack).
Storage
- Store at temperature not exceeding 30°C.
- Keep in dry place, protect from light.
- Keep out of reach of children.
Council of Arab Health Ministers and Union of Arab Pharmacists |
Produced by: El Nasr Pharmaceutical Chemicals Co. “ADWIC” Abu-Zaabal – A.R.E.. ATC Code: J01MB02
Dr. Ahmad Baker, PharmD
Senior Pharmacist & Health Educator
With over 23 years of clinical experience in hospital and community pharmacy across Egypt and Saudi Arabia, Dr. Ahmad specializes in reproductive health and pharmaceutical safety. He is dedicated to providing evidence-based guidance to empower patients in the MENA region.
Medical Disclaimer: This content is for educational purposes and reflects the latest pharmaceutical protocols. It is not a substitute for personal medical advice. Always consult Dr. Ahmad Baker or your healthcare provider before starting any treatment.

